JAC Advance Access originally published online on May 10, 2006
Journal of Antimicrobial Chemotherapy 2006 58(1):198-201; doi:10.1093/jac/dkl181
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria
1 Institute of Dental Sciences, Hebrew University-Hadassah School of Dental Medicine, The Hebrew University of Jerusalem Jerusalem, Israel 2 Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem Jerusalem, Israel 3 Laboratory of Antimicrobial Peptides Investigation (LAPI), Department of Biotechnology & Food Engineering, Technion–Israel Institute of Technology Haifa, Israel
Received 16 December 2005; returned 2 March 2006; revised 2 April 2006; accepted 16 April 2006
*Corresponding author. Tel: +972-2-6757117; Fax: +972-2-6758561; E-mail: bgilad{at}md.huji.ac.il
Background: Antimicrobial peptides are components of the innate immunity that play an important role in systemic and oral health.
Objectives: The antibacterial activity of the amphibian-derived K4-S4(1-15)a antimicrobial peptide was tested against oral pathogens associated with caries and periodontitis and compared with the activities of the human-derived antimicrobial peptides LL-37 and dhvar4a.
Methods: Growth inhibition of planktonic bacteria was tested using standard microdilution assays. Live/Dead staining followed by confocal scanning laser microscopy (CSLM) was used to determine the bactericidal effect of K4-S4(1-15)a on Streptococcus mutans attached to a glass surface or grown as biofilm.
Results: The cariogenic species S. mutans, Streptococcus sobrinus, Lactobacillus paracasei and Actinomyces viscosus were resistant to LL-37 found in the oral cavity. Porphyromonas gingivalis was the species most resistant to the three tested peptides. K4-S4(1-15)a demonstrated the highest activity against the tested planktonic bacteria. In addition, K4-S4(1-15)a was bactericidal to surface-attached S. mutans as well as to S. mutans biofilms grown in vitro. However, surface attachment increased S. mutans resistance to the antimicrobial peptide.
Conclusions: Our results support growing evidence suggesting the use of antimicrobial peptides for prevention and treatment of oral disease.
Keywords: oral infection , biofilm , LL-37 , dermaseptin , histatin-5
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Flemming, C. Klingenberg, J. P. Cavanagh, M. Sletteng, W. Stensen, J. S. Svendsen, and T. Flaegstad High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms J. Antimicrob. Chemother., January 1, 2009; 63(1): 136 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gelhaus, T. Jacobs, J. Andra, and M. Leippe The Antimicrobial Peptide NK-2, the Core Region of Mammalian NK-Lysin, Kills Intraerythrocytic Plasmodium falciparum Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1713 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bachrach, H. Altman, P. E. Kolenbrander, N. I. Chalmers, M. Gabai-Gutner, A. Mor, M. Friedman, and D. Steinberg Resistance of Porphyromonas gingivalis ATCC 33277 to Direct Killing by Antimicrobial Peptides Is Protease Independent Antimicrob. Agents Chemother., February 1, 2008; 52(2): 638 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Porat, K. Marynka, A. Tam, D. Steinberg, and A. Mor Acyl-Substituted Dermaseptin S4 Derivatives with Improved Bactericidal Properties, Including on Oral Microflora Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4153 - 4160. [Abstract] [Full Text] [PDF]
|
|